| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/20/2005 | CN1642947A Crystalline forms of (2S)-N-5[amino(imino)methyl]-2-thienylmethyl-1-(2R)-2[(carboxymethyl) amino]-3, 3-diphenylpropanoyl-2-pyrrolidinecarboxamide nHO |
| 07/20/2005 | CN1642946A Maleic acid salt of(2s)-N-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2R)-2-[(carboxymethyl)amino]-3, 3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing same |
| 07/20/2005 | CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same |
| 07/19/2005 | US6919423 A 2-thiazole-4-(pyrrole-3yl)-oxo-7-methoxyquinoline derivatives, a protease enzyme inhibitors, for treating viral disease |
| 07/19/2005 | US6919315 Administering a patient an effective amount of a triamide compound to treat the medical disorders resulting from a deficiency in growth hormone |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919180 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 07/14/2005 | WO2005063795A1 Glutathione derivatives and their uses for the treatment of viral diseases |
| 07/14/2005 | WO2005040142B1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/14/2005 | WO2005021494A9 D-amino acid peptides |
| 07/14/2005 | WO2005002508A3 Macromolecular platinum chelates |
| 07/14/2005 | WO2004094453A3 Filtration of dipeptide and dipeptide derivative sweeteners |
| 07/14/2005 | US20050154229 Salt formation from the free base and maleic acid in the presence of an alcohol solvent to obtain the amorphous salt form, and then recrystallization; thrombin inhibitors with optimal solubility and no deliquescence |
| 07/14/2005 | US20050154186 Removal of ruthenium by-product by supercritical fluid processing |
| 07/14/2005 | US20050154185 Vitronectin receptor antagonist pharmaceuticals |
| 07/14/2005 | US20050153903 Inhibitors of enzymes for treatment of Aids or making intermediates |
| 07/14/2005 | US20050153901 Of EtO2C CH2 (R)Cgl-Aze-Pab-OH or its salt; high chemical and solid state stability; thrombin inhibitors |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050153877 Macrocyclic hepatitis C serine protease inhibitors |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/13/2005 | EP1553184A1 Process for producing tripeptide or higher peptide |
| 07/13/2005 | EP1553177A1 Method of designing physiologically active peptide and use thereof |
| 07/13/2005 | EP1553171A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 07/13/2005 | EP1551865A2 Hybrid molcules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 07/13/2005 | EP1551864A1 Substrate for tafi (a) |
| 07/13/2005 | EP1551863A2 Method for synthesizing peptides comprising at least one glycine molecule |
| 07/13/2005 | EP1551801A1 Novel gamma-lactams as beta-secretase inhibitors |
| 07/13/2005 | EP1551441A1 Peptides and recombinant proteins mimicking interferons |
| 07/13/2005 | EP1001976B1 Peptides having potassium channel opener activity |
| 07/13/2005 | CN1639187A Macrocyclic peptides active against the hepatitis C virus |
| 07/13/2005 | CN1639186A Inhibitors of kallikrein |
| 07/13/2005 | CN1639109A Dynamic resolution of isomers and resolved isomers |
| 07/13/2005 | CN1637018A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1210304C Sequence number 3 bioactive peptide |
| 07/13/2005 | CN1210301C Bioactive peptide sequential No.18 |
| 07/13/2005 | CN1210300C Bioactive peptide No.29 |
| 07/13/2005 | CN1210299C Sequence No.19 biological active peptide |
| 07/13/2005 | CN1210298C Sequence number 1 bioactive peptide |
| 07/13/2005 | CN1210297C Bioactive peptide sequential No.17 |
| 07/13/2005 | CN1210296C Sequential bioactive peptide No.30 |
| 07/13/2005 | CN1210295C Sequential No.24 bioactive peptide |
| 07/13/2005 | CN1210294C Sequential No.21 bioactive peptide |
| 07/13/2005 | CN1210293C Sequential No.23 bioactive peptide |
| 07/13/2005 | CN1210292C Bioactive peptide sequential No.22 |
| 07/13/2005 | CN1210291C Novel aspartame derivative crystal and process for producing same |
| 07/13/2005 | CN1210290C Delivery of nucleic acids |
| 07/12/2005 | US6916905 Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916607 Gene controlling androgen |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/07/2005 | WO2005061529A1 Peptide inhibiting angiontensin converting enzyme |
| 07/07/2005 | WO2005061452A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/07/2005 | WO2005061437A2 Isopeptide gap junction modulators |
| 07/07/2005 | WO2004108938B1 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148572 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 07/07/2005 | US20050148564 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/07/2005 | US20050148515 Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics |
| 07/07/2005 | US20050147568 nanostructured acid addition salt of 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, used for the treatment of headaches |
| 07/07/2005 | DE10356409A1 Neues Arzneimittel Oxachelin und Derivate New drug Oxachelin and derivatives |
| 07/07/2005 | DE10105038B4 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 07/07/2005 | CA2550632A1 Isopeptide gap junction modulators |
| 07/07/2005 | CA2550215A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/06/2005 | EP1549334A1 A pharmaceutical composition comprising a retro-iverso isomer pettide |
| 07/06/2005 | EP1140909B1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2005 | EP1071442B1 Methods and compositions for peptide synthesis (t-20) |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | CN1634977A Process for preparing aspartame |
| 07/06/2005 | CN1209368C Novel acetamide derivative and use thereof |
| 07/06/2005 | CN1209363C Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/05/2005 | US6914151 N-(3,3-dimethylbutyl)-APM is obtained by crystallization using methanol and water as the crystallization solvent |
| 07/05/2005 | US6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/05/2005 | US6913919 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/05/2005 | CA2298639C Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 06/30/2005 | WO2005059140A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | WO2005058943A1 Biphenyl-substituted antibacterial macrocycles |
| 06/30/2005 | WO2005058821A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | WO2005042560A3 Non-viral delivery of compounds to mitochondria |
| 06/30/2005 | WO2005012334A8 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143391 Heterocyclic amides with alpha-4 integrin antagonist activity |
| 06/30/2005 | US20050143318 ((1R)-2-indol-3-yl-1-{N-[1-(2-oxo-1-phenyl-2-pyrrolidinylethyl)imidazol-4-yl]carbamoyl)ethyl)-2-[(tert-butoxy)carbonylamino]-2-methylpropanamide; combinded with bone-antiresorptive agent selected from selective estrogen receptor modulators, bisphosphonates, calcitonin, and PTH; carrieres, excipients |
| 06/30/2005 | US20050143317 Compounds and methods for treatment of thrombosis |
| 06/30/2005 | US20050143316 Hepatitis C virus inhibitors |
| 06/30/2005 | US20050143312 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/30/2005 | CA2550028A1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 06/30/2005 | CA2549874A1 Antibacterial macrocycles with substituted biphenyl |
| 06/30/2005 | CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/29/2005 | EP1548026A1 Novel depsipeptide compound |
| 06/29/2005 | EP1547999A1 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 06/29/2005 | EP1547590A1 Melanin extinguisher |
| 06/29/2005 | EP1545638A1 Controlled release therapeutic wound dressings |
| 06/29/2005 | EP1545613A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 06/29/2005 | EP1545580A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 06/29/2005 | EP1487826A4 NEW CRYSTALLINE FORMS OF (2S)-N-5-(AMINO(IMINO)METHYL)-2-THIENYLMETHYL-1-(2R)-2-((CARBOXYMETHYL)AMINO)-3,3-DIPHENYLPROPANOYL-2-PYRROLIDINECARBOXAMIDE.nH2O |